Article thumbnail
Location of Repository

Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration

By S Jane Millward-Sadler, Patrick W Costello, Anthony J Freemont and Judith A Hoyland
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2714110
Provided by: PubMed Central

Suggested articles

Citations

  1. (2000). A: The economic burden of back pain in the UK.
  2. (1998). Aebi M: Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages. Virchows Archiv
  3. (2007). Analysis of tissue distribution of TNF-alpha, TNF-alphareceptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Ann NY Acad Sci
  4. (1996). den: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum
  5. (2007). Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: from gene to behavior.
  6. (2001). E: The role of ADAMTS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage
  7. (2005). Expression and distribution of tumor necrosis factor alpha in human lumbar intervertebral discs: a study in surgical specimen and autopsy controls. Spine
  8. (1975). Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro.
  9. (2007). Freemont AJ: Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1beta and TNFalpha expression profile. Arthritis Res Ther
  10. (2002). Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol
  11. (2007). Freemont AJ: Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res Ther
  12. (2008). Freemont AJ: Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology (Oxford)
  13. (2000). GR: Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes.
  14. (2002). HS: mRNA expression of cytokines and chemokines in herniated lumbar intervertebral discs. Spine
  15. (2006). Human disc degeneration is associated with increased MMP 7 expression. Biotech Histochem
  16. (1995). Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum
  17. (1989). Inhibitory effect of TNF alpha antibodies on synovial cell interleukin1 production in rheumatoid arthritis. Lancet
  18. (2001). Intervertebral disc cells exhibit differences in gene expression in alginate and monolayer culture. Spine
  19. (2006). JA: A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.
  20. (2004). JA: Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc.
  21. (2005). JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther
  22. (1994). Loo FA van de: Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol
  23. (1992). Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
  24. (2007). Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans
  25. (1995). Panayi GS: Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis pathogenetic implications. Arthritis Rheum
  26. (2009). Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrixArthritis
  27. (2003). Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55. J Rheumatol
  28. (2002). SSE Award Competition in Basic Science: expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption. Eur Spine J
  29. (2005). Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine
  30. (1993). Vosbeck K: Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collageninduced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.